F. A. Orsi

发表

Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study

S. le Cessie, O. Dekkers, F. Rosendaal, 2021, British journal of haematology.

Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism

E. V. de Paula, J. Annichino-Bizzacchi, F. A. Orsi, 2015, Scientific Reports.

Risk Factors for Transfusion after Orthotopic Liver Transplantation

J. Kutner, F. A. Orsi, A. Yokoyama, 2019, Transfusion Medicine and Hemotherapy.

Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden

E. V. de Paula, J. Annichino-Bizzacchi, I. Lorand-Metze, 2009, Platelets.

Plasma Factor VIII Levels as a Biomarker for Venous Thromboembolism

J. Annichino-Bizzacchi, M. Colella, F. A. Orsi, 2015 .

Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome.

B. W. Hounkpe, E. V. de Paula, J. Annichino-Bizzacchi, 2022, Thrombosis research.

Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome

J. Annichino-Bizzacchi, M. Lazarini, F. A. Orsi, 2020, Journal of Thrombosis and Thrombolysis.

Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome.

E. V. de Paula, J. Annichino-Bizzachi, M. Colella, 2018, Thrombosis research.

Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.

E. V. de Paula, J. Annichino-Bizzacchi, S. Appenzeller, 2016, Thrombosis research.

Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response.

E. V. de Paula, S. Appenzeller, J. Annichino-Bizzachi, 2015, Thrombosis research.

Home management of INR in the public health system: feasibility of self-management of oral anticoagulation and long-term performance of individual POC devices in determining INR

E. V. de Paula, J. Annichino-Bizzacchi, C. Costa-Lima, 2016, Journal of Thrombosis and Thrombolysis.

Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19

L. Velloso, S. Strickland, A. Ilich, 2022, Blood Advances.

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk

F. Rosendaal, A. Van der Laarse, S. Cannegieter, 2019, Clinical epidemiology.

Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome

B. W. Hounkpe, J. Annichino-Bizzacchi, S. Appenzeller, 2022, Lupus.

Use of hydroxychloroquine to control immune response and hypercoagulability in patients with primary antiphospholipid syndrome.

F. A. Orsi, Bruna Mazetto, C. Vaz, 2021, European journal of internal medicine.

Obstetric antiphospholipid syndrome

F. A. Orsi, Ana Maria Kondo Igai, V. I. P. Barros, 2021, Revista Brasileira de Ginecologia e Obstetricia / RBGO - Gynecology and Obstetrics.

Performance of a point‐of‐care device in determining prothrombin time in supra‐therapeutic INRs

E. V. de Paula, J. Annichino-Bizzacchi, M. Colella, 2013, International journal of laboratory hematology.

Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event

A. V. C. Romano, E. V. de Paula, J. Annichino-Bizzacchi, 2021, Journal of Thrombosis and Thrombolysis.

Adenosine diphosphate‐induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t‐PAPS): Role of P2Y12‐cAMP signaling pathway

C. H. Lescano, F. Mónica, F. A. Orsi, 2022, Journal of thrombosis and haemostasis : JTH.

Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020

A. Nicolaides, R. Lopes, C. Carter, 2020, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.

E. V. de Paula, J. Annichino-Bizzacchi, M. Colella, 2019, Vascular pharmacology.

Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels.

E. V. de Paula, J. Annichino-Bizzacchi, F. A. Orsi, 2014, Thrombosis research.

Increased inflammation and endothelial markers in patients with late severe post-thrombotic syndrome

J. Annichino-Bizzacchi, F. A. Orsi, L. F. Bittar, 2020, PloS one.

Association of acidosis with coagulopathy and transfusion requirements in liver transplantation

Â. Luzo, E. C. de Ataíde, F. A. Orsi, 2021, Journal of Thrombosis and Thrombolysis.

Acquired thrombotic thrombocytopenic purpura due to antibody-mediated ADAMTS13 deficiency precipitated by a localized Castleman’s disease: A case report

J. Annichino-Bizzachi, E. V. Paula, M. Colella, 2015, Platelets.

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database

E. V. de Paula, J. Annichino-Bizzacchi, S. Barco, 2022, Research and Practice in Thrombosis and Haemostasis.

Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model

E. V. de Paula, C. Levy, F. A. Orsi, 2019, PloS one.

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

F. Rosendaal, F. Leebeek, M. Kruip, 2019, Journal of thrombosis and haemostasis : JTH.